Skip to content

Patients › General-Health

Viêm khớp do viêm và viêm khớp dạng thấp

Rheumatoid, psoriatic and gouty arthritis affecting the hand, wrist and upper limb — what they are, how they are managed, and when surgery helps.

Updated Oct 2026
Bàn tay có các khớp ngón sưng phù.
Viêm khớp do viêm tấn công lớp màng lót khớp, gây sưng, cứng khớp và, nếu không được điều trị, gây tổn thương khớp. Kieran Hirpara 4.0

Trang này được dịch bằng máy và chưa được bác sĩ kiểm tra. Bản tiếng Anh là bản chính thức.

Những cảm giác mà bạn đang trải qua

Viêm khớp do viêm, bao gồm viêm khớp dạng thấp, là tình trạng hệ miễn dịch của bạn tấn công lớp màng lót bên trong chính các khớp của bạn. Ở bàn tay và cổ tay, điều này gây sưng và đau ở các khớp nhỏ của ngón tay và ở chính cổ tay. Tình trạng sưng thường nặng nhất khi bạn thức dậy vào buổi sáng, và có thể dịu dần khi bạn bắt đầu vận động. Cho bàn tay nghỉ ngơi thường làm cơn đau dịu đi, còn sử dụng bàn tay thì làm tình trạng nặng hơn.

Trong sinh hoạt hằng ngày, điều này thể hiện ở những việc cần cầm nắm và cử động ngón tay khéo léo. Xoay chìa khóa, mở nắp lọ, cầm bút, cài cúc áo hoặc xách ấm nước đều có thể trở nên khó khăn hơn. Một số người nhận thấy một ngón tay hoặc một khớp đốt ngón tay sưng nhiều hơn những chỗ khác. Theo thời gian, các khớp có thể bị thay đổi hình dạng, và các gân giúp duỗi thẳng ngón tay có thể bị mòn đứt và không còn hoạt động đúng cách.

Bệnh cũng có thể ảnh hưởng đến các khớp khác, bao gồm khuỷu tay và vai, và có thể khiến bạn cảm thấy không khỏe trong người khi bệnh bùng phát. Những cục u dưới da, gọi là hạt thấp (nốt dạng thấp), đôi khi xuất hiện ở các điểm tì đè như mu bàn tay hoặc mặt sau khuỷu tay.

Một số dấu hiệu cảnh báo cần được xử trí nhanh. Nếu một ngón tay, bàn tay hoặc cánh tay trở nên nóng, đỏ, sưng và đau, đặc biệt khi kèm theo sốt, hãy đến khoa cấp cứu ngay trong ngày. Nếu các ngón tay hoặc bàn tay trở nên nhợt nhạt, lạnh, trắng bệch hoặc tím tái, hoặc bạn đột ngột mất cảm giác hoặc mất khả năng cử động sau một chấn thương, hãy đến khoa cấp cứu ngay trong ngày.

Những dấu hiệu khác cần được thăm khám chứ không cần đến khoa cấp cứu. Hãy đến gặp bác sĩ đa khoa hoặc yêu cầu được bác sĩ chuyên khoa thăm khám nếu các triệu chứng không thuyên giảm, nặng dần lên trong nhiều tuần, làm bạn thức giấc vào ban đêm, hoặc khiến bạn không thể làm việc hay sử dụng bàn tay.

Điều gì đang thực sự xảy ra

Ở một khớp khỏe mạnh, lớp màng lót mỏng và trơn láng, và tiết ra một lượng nhỏ dịch giúp các bề mặt khớp trượt lên nhau. Trong viêm khớp dạng thấp, hệ miễn dịch của bạn coi lớp màng lót đó như một vật lạ và tấn công nó. Lớp màng lót trở nên dày lên và bị viêm, và tiết ra quá nhiều dịch. Lớp màng lót sưng phồng đó sau đó bắt đầu ăn mòn chính các bề mặt khớp, làm mòn đi lớp sụn trơn láng lẽ ra phải bảo vệ xương.

Tổn thương không dừng lại ở khớp. Chính mô bị viêm đó có thể bao quanh các gân, tức là những dây chạy từ các cơ ở cẳng tay đến các ngón tay và giúp bạn gập và duỗi ngón tay. Mô đó có thể làm yếu gân cho đến khi gân bị sờn hoặc mòn đứt, đó là lý do một ngón tay có thể đột nhiên không duỗi thẳng được nữa. Nó cũng có thể làm mềm chính xương, khiến xương yếu hơn và dễ bị bào mòn hơn, đặc biệt là quanh cổ tay và các khớp nhỏ của ngón tay.

Điều này giải thích những gì bạn đang cảm thấy. Tình trạng cứng và sưng khớp buổi sáng xuất phát từ lớp màng lót bị viêm tiết ra thêm dịch. Cơn đau khi sử dụng xuất phát từ các bề mặt khớp bị trầy trợt, không còn được bảo vệ, cọ xát vào nhau. Hình dạng khớp thay đổi khi các bề mặt bị mòn và các gân bị yếu khiến ngón tay lệch dần khỏi trục. Và những cục u dưới da, tức là các hạt thấp đã nhắc ở trên, là một phần của cùng quá trình bệnh chứ không phải một vấn đề riêng biệt.

Bệnh biểu hiện khác nhau ở mỗi người. Một số người mắc thể nhẹ hơn, tiến triển chậm hơn, trong khi những người khác mắc thể nặng hơn, làm tổn thương khớp và gân nhanh hơn. Tốc độ cổ tay hoặc các ngón tay của bạn xấu đi phụ thuộc vào kiểu bệnh mà bạn mắc. Đó là lý do việc điều trị đạt hiệu quả tốt nhất khi bản thân tình trạng viêm được kiểm soát, thường bằng thuốc do bác sĩ chuyên khoa thấp khớp của bạn kê, trước hoặc song song với bất kỳ ca phẫu thuật nào trên bàn tay.

Những biện pháp chúng tôi có thể áp dụng

Có rất nhiều điều bạn có thể tự làm song song với việc điều trị y khoa. Tập thể dục nhẹ nhàng, đều đặn giúp các khớp tiếp tục cử động và có thể cải thiện sức mạnh theo thời gian, mặc dù tác dụng giảm cứng khớp thường chỉ ngắn hạn. Nếu viêm khớp dạng thấp của bạn được kiểm soát tốt, các chương trình tập luyện có giám sát kết hợp tập sức mạnh với tập luyện cường độ cao hơn nhìn chung được dung nạp tốt và có thể giúp ích cho sức khỏe thể chất tổng thể của bạn. Chuyên viên hoạt động trị liệu cũng có thể chỉ cho bạn những cách bảo vệ khớp và giúp các công việc hằng ngày dễ dàng hơn. Hãy thử những cách này một cách nghiêm túc trong nhiều tuần chứ không chỉ vài ngày, và tiếp tục duy trì ngay cả khi bạn bắt đầu các phương pháp điều trị khác.

Thuốc là phương pháp điều trị chủ yếu, đặc biệt là ở giai đoạn đầu. Thuốc chống viêm và corticosteroid giúp làm dịu cơn đau và tình trạng sưng. Các thuốc khác, chẳng hạn như methotrexate, tác động lên chính căn bệnh bằng cách làm dịu hệ miễn dịch đang hoạt động quá mức của bạn, và các thuốc sinh học mới hơn nhắm vào những phần cụ thể của quá trình viêm. Những loại thuốc này đã thay đổi diễn tiến của bệnh ở nhiều người, đến mức hiện nay số người cần phẫu thuật thay khớp đã ít hơn nhiều so với trước đây. Đổi lại, các thuốc làm giảm hoạt động của hệ miễn dịch sẽ làm tăng nguy cơ nhiễm trùng của bạn, vì vậy cần được quản lý cẩn thận, đặc biệt là trong giai đoạn quanh bất kỳ ca phẫu thuật nào.

Nếu các triệu chứng vẫn nặng dù đã áp dụng những biện pháp này, bác sĩ đa khoa hoặc bác sĩ chuyên khoa thấp khớp có thể giới thiệu bạn để được bác sĩ chuyên khoa đánh giá bàn tay và cổ tay. Phẫu thuật không phải là bước đầu tiên, và chỉ được cân nhắc khi bệnh đã làm tổn thương khớp hoặc gân theo những cách mà thuốc không thể đảo ngược. Đối với một số vấn đề cụ thể, đôi khi phẫu thuật có thể giúp giảm đau hoặc cải thiện chức năng. Mọi quyết định đều tính đến các khớp khác của bạn, những việc bạn cần đôi tay làm được, và lối sống của bạn.

Những điều có thể mong đợi

Viêm khớp dạng thấp là một bệnh kéo dài. Bệnh không tự khỏi, và có xu hướng tiếp tục làm tổn thương khớp nếu tình trạng viêm không được kiểm soát. Tổn thương khớp thường bắt đầu trong năm đầu tiên hoặc năm thứ hai của bệnh và tiếp diễn từ đó. Đó là lý do điều trị sớm rất quan trọng: thuốc làm dịu tình trạng viêm có thể làm chậm hoặc ngăn chặn tổn thương đó trước khi nó xảy ra.

Khi bệnh được kiểm soát tốt, triển vọng đã thay đổi đối với nhiều người. Các thuốc hiện đại đã làm giảm tần suất khớp bị hư hại nặng đến mức cần phẫu thuật thay khớp. Với điều trị, các đợt bùng phát có thể dịu xuống và bạn có thể tiếp tục sử dụng đôi tay cho các công việc hằng ngày. Nếu bệnh của bạn được kiểm soát tốt, tập thể dục đều đặn, bao gồm tập sức mạnh và tập luyện cường độ cao hơn, nhìn chung được dung nạp tốt và giúp ích cho sức khỏe tổng thể của bạn.

Nếu để bệnh diễn tiến mà không điều trị, lớp màng lót bị viêm tiếp tục ăn mòn bề mặt khớp và gân. Các khớp có thể thay đổi hình dạng, các ngón tay có thể lệch dần khỏi trục, và các gân giúp duỗi thẳng ngón tay có thể bị mòn đứt. Một gân đã bị mòn đứt sẽ không tự lành hoặc tự ổn định, và cần được bác sĩ chuyên khoa thăm khám kịp thời. Tổn thương đã xảy ra ở sụn và xương không thể được đảo ngược bằng thuốc.

Phẫu thuật có thể giúp ích khi tổn thương đã xảy ra. Những người được thay khớp cho một khớp bị tổn thương cho biết họ ít đau hơn và chức năng tốt hơn sau đó. Kết quả khác nhau ở mỗi người, và một mức độ xấu đi nhất định có thể xảy ra về lâu dài, vì vậy phẫu thuật là bước được thực hiện khi thuốc không còn kiểm soát được vấn đề.

Hãy để ý những dấu hiệu đã được mô tả ở phần trên của trang này. Nếu một ngón tay hoặc bàn tay trở nên nóng, đỏ, sưng và đau, đặc biệt khi kèm theo sốt, hãy đến khoa cấp cứu ngay trong ngày. Nếu các ngón tay trở nên nhợt nhạt, lạnh, trắng bệch hoặc tím tái, hoặc bạn đột ngột mất cảm giác hoặc mất khả năng cử động sau một chấn thương, cũng hãy đến khoa cấp cứu ngay trong ngày. Nếu các triệu chứng không thuyên giảm, nặng dần lên trong nhiều tuần, làm bạn thức giấc vào ban đêm, hoặc khiến bạn không thể làm việc hay sử dụng bàn tay, hãy đến gặp bác sĩ đa khoa hoặc yêu cầu được bác sĩ chuyên khoa thăm khám.

Khi nào nên đi khám bác sĩ

Đây là một bệnh do viêm, vì vậy các dấu hiệu cảnh báo khác với một khớp chỉ đơn thuần bị hao mòn. Những dấu hiệu khẩn cấp đã được đề cập ở phần trên của trang này: nếu một ngón tay, bàn tay hoặc cánh tay trở nên nóng, đỏ, sưng và đau, đặc biệt khi kèm theo sốt, hãy đến khoa cấp cứu ngay trong ngày. Cũng hãy đến khoa cấp cứu ngay trong ngày nếu các ngón tay trở nên nhợt nhạt, lạnh, trắng bệch hoặc tím tái, hoặc nếu bạn đột ngột mất cảm giác hoặc mất khả năng cử động sau một chấn thương.

Hãy đến gặp bác sĩ đa khoa hoặc yêu cầu được bác sĩ chuyên khoa thăm khám nếu các triệu chứng của bạn không thuyên giảm, nặng dần lên trong nhiều tuần, làm bạn thức giấc vào ban đêm, hoặc khiến bạn không thể làm việc hay sử dụng bàn tay. Một ngón tay đột nhiên không duỗi thẳng được nữa cũng cần được bác sĩ chuyên khoa thăm khám kịp thời, vì một gân đã bị mòn đứt sẽ không tự lành.

Hãy yêu cầu được thăm khám càng sớm càng tốt nếu bạn nhận thấy một khớp đang thay đổi hình dạng hoặc lệch dần khỏi trục, hoặc nếu tình trạng sưng và cứng khớp buổi sáng cứ tái đi tái lại. Tình trạng viêm được kiểm soát càng sớm thì cơ hội bảo vệ các khớp trước khi tổn thương xảy ra càng cao.


Evidence & references

This is the clinical evidence summary written for health professionals. It is technical, and it lists the research this page was built from. You do not need to read it to understand your treatment or to make a decision about it.

Overview

  • The success of treatment for patients with rheumatoid arthritis depends on a clear understanding of available drugs and what can be done at various stages of the disease [1].
  • Arthritic disorders have a profound importance to the general population as a health problem and for their social and economic impact [2].
  • Long-term results of radiolunate arthrodesis in the rheumatoid wrist are favorable as long as the rheumatoid process is under control [3].
  • Cy3-tilmanocept labeling of macrophages establishes a novel tool for pre-clinical research of early arthritis and has implications for early RA detection and monitoring of therapeutic efficacy in humans [4].
  • Economic, social, and cultural factors affect rheumatoid hand treatment in selected countries representing various regions of the world [5].
  • Patients with rheumatoid arthritis can differentiate between problems caused by their hands and other effects of their disease [6].
  • Complication rates are comparable between RA and non-RA cohorts in total elbow arthroplasty, but further investigation into the underlying mechanisms of increased revision rates in RA patients is warranted [7].
  • Surgery for rheumatoid arthritis involves medical considerations, surgical principles, and regional surgical considerations [8].
  • Rheumatoid nodules are often associated with the severe form of rheumatoid disease, which carries a poor prognosis [9].
  • Retrospective case reports and pictorial depictions question the belief that rheumatoid arthritis is a modern disease brought to the Old World from the New World after the discovery of America [11].
  • Rheumatoid wrist involvement in black patients was more or less the same as reported in other series, but finger joint involvement was considerably less [12].
  • Following total shoulder arthroplasty, RA patients should be considered at higher risk of systemic and joint-related complications compared to patients with primary osteoarthritis [13].
  • Clinical symptoms and radiologic appearances are often poor indicators of the source of pain in the shoulder joint complex in patients with rheumatoid arthritis [14].
  • Rheumatologists view rheumatoid hand surgery as significantly less effective than do hand surgeons, highlighting disagreements between the two specialties about the management of this clinical problem [15].
  • A system of radiographic grading for rheumatoid, psoriatic, and other similar arthritic conditions can be useful in evaluating cases for both medical and surgical treatment and epidemiologic studies [17].
  • Systemic inflammatory diseases other than rheumatoid arthritis affect the hand with skin, vascular, and musculoskeletal symptoms [18].
  • Surgery for rheumatoid arthritis and other inflammatory diseases is not disappearing [20].
  • The book 'Monoclonal antibodies, cytokines, and arthritis' presents concepts regarding the molecular biology and immunology of arthritides and a new rationale for treatment [26].
  • There is limited knowledge of anti-TNFa and no consensus of opinion amongst hand surgeons performing rheumatoid surgery in the UK with regard to its perioperative use [31].

Background & Causes

  • Cy3-tilmanocept labeling of macrophages establishes a novel tool for pre-clinical research of early arthritis with implications for early RA detection and monitoring of therapeutic efficacy in humans [4].
  • Further investigation into the underlying mechanisms of increased revision rates in RA patients is warranted despite comparable complication rates between RA and non-RA cohorts in total elbow arthroplasty [7].
  • Data on total joint arthroplasty trends likely reflect skewed utilization of bDMARDs in rheumatoid arthritis patients with more severe disease and prolonged periods of joint degeneration because of prior treatment failure [10].
  • Following total shoulder arthroplasty, RA patients should be considered at higher risk of systemic and joint-related complications compared to patients with primary OA [13].
  • Denosumab demonstrates promising efficacy in maintaining bone health and preventing joint damage in rheumatoid arthritis patients with coexisting osteoporosis [16].
  • Rheumatoid arthritis is characterized by maintained mineralization and no predominant periarticular osteopenia, which contrasts with gout [29].
  • Rheumatoid patients with diabetes had an increased risk of wound infection (33%) compared with patients without (3.3%) after elective rheumatoid hand and wrist surgery [33].
  • Hand involvement in psoriatic arthritis differs from rheumatoid arthritis, characterized by stiffness and spontaneous fusion rather than instability [38].
  • Inflammatory arthritis represents a distinctly morbid risk profile compared to osteoarthritis patients with multiple increased surgical and postoperative medical complications in patients undergoing aTSA and rTSA [40].
  • The ongoing rheumatoid process is responsible for the translocation observed after resection of the distal ulna in rheumatoid arthritis [41].
  • Inflammatory arthritis has a substantial effect in producing intracortical defects in metaphyseal bone, but the bisphosphonate zoledronate was considerably effective in preventing these changes from occurring [47].
  • In vivo, mechanically impaired tendons may play an important role in destabilization of the wrist in patients with rheumatoid arthritis [28].
  • Early in the disease process of rheumatoid arthritis, bone erosions may occur in the sigmoid notch of the distal radius [44].
  • Severe joint destruction in autoimmune arthritis caused by Candida septic arthritis may have been the result of prolonged sepsis, development of an autoimmune response to Candida breakdown products, or a combination of these factors [45].
  • The density of synovial cells increased after synovectomy in all control subjects and six of eight RA patients, which is indicative of a wound healing response [46].
  • Type II collagen was present in all attachment zones of the proximal interphalangeal joint, although there was little in rheumatoid fingers [48].
  • Invasive tenosynovium is more destructive than encapsulating tenosynovium at a molecular level, providing an explanation for the increased tendon rupture associated with invasive tenosynovitis in RA [68].
  • Surgery of the rheumatoid hand must take account of the severity of the disease, with sero-positive patients with high sedimentation rates being informed about and trained in principles of joint protection before operation [72].
  • Understanding which factors are associated with choosing rheumatoid hand reconstruction is an essential component of patient preoperative counseling [73].
  • There is a significantly lower incidence of Dupuytren's features in patients with rheumatoid diseases than there is in random control patients [74].

Symptoms & Presentation

General Clinical Presentation

  • Juvenile rheumatoid arthritis seldom involves the small joints of the hand, but proximal interphalangeal joint synovitis can be the initial manifestation [49].
  • Single-digit swelling may be a presenting feature of juvenile rheumatoid arthritis in 18% of cases [60].
  • A misdiagnosis of rheumatoid nodules was made secondary to the patient’s history of rheumatoid arthritis [23].
  • In rheumatoid arthritis, mineralization is maintained and there is no predominant periarticular osteopenia [29].

Mechanical and Structural Findings

  • Radiologic examination showed that all patients exhibited resorption of the distal ulna (mean 4.4 mm) and that resorption was worst in the group with rheumatoid arthritis [65].
  • The use of contrast arthrography can provide evidence as to the presence and prominence of rheumatoid synovitis at the elbow [67].

Prognostic and Outcome Indicators

  • FPL rupture in patients with rheumatoid arthritis gives short term dysfunction but, in most cases, not substantial medium-term dysfunction [27].
  • Age, disease duration, disease activity score and deformity were associated with the lowest bMHQ scores in RA patients [34].
  • The severity of the patient's disease and the degree of articular involvement had a great effect on the outcome of surgery [63].
  • Overall functional results often were affected by the status of disease in other joints, but in general were acceptable [71].

Management

General Principles and Multidisciplinary Care

  • The goal of medical and surgical management for patients with rheumatoid arthritis is to maintain or improve functional capacity [43].
  • Surgery for rheumatoid arthritis requires a comprehensive team approach that includes medical considerations, surgical principles, and regional surgical considerations [8].
  • In all facets of treatment or evaluation, the rheumatoid patient must be handled gently with respect to tissue response and pain [52].
  • All care plans for the rheumatoid hand should be made with thoughtful consideration to the patient's other joint involvement, functional needs, and lifestyle [50].
  • Rheumatologists view rheumatoid hand surgery as significantly less effective than do hand surgeons, highlighting disagreements between the two specialties regarding management [15].
  • Two-thirds of patients with rheumatic conditions visiting a multidisciplinary hand clinic reportedly followed the treatment advice, with an overall trend toward a beneficial effect on hand function [54].

Medical Management and Pharmacology

  • Pharmacologic agents used in rheumatoid arthritis include nonsteroidal antiinflammatory drugs, corticosteroids, methotrexate, and biologic agents [43].
  • Biologic agents are recombinant proteins that generally target an inflammatory cytokine, such as tumor necrosis factor [43].
  • Biologic agents have shown excellent results in rheumatoid arthritis treatment [43].
  • Biologic agents inhibit the immune system and cause an increased risk of infection in patients taking them [43].
  • There is preclinical evidence for an antioxidant, anti-inflammatory, antinociceptive, cartilage- and bone-protective effect of calcitonin in rheumatoid arthritis and osteoarthritis [59].
  • Tectochrysin may be a novel rheumatoid arthritis therapeutic agent, likely acting via macrophage JAK/STAT pathway inhibition, with promising clinical potential [53].
  • Cy3-tilmanocept labeling of macrophages establishes a novel tool for pre-clinical research of early arthritis and has implications for early rheumatoid arthritis detection and monitoring of therapeutic efficacy in humans [4].

Perioperative Considerations

  • Patients who are on corticosteroids generally require preoperative “stress” dosages of hydrocortisone [43].
  • Agents that inhibit the immune system should be withheld at least 1 week before and 1 week after a surgical procedure for rheumatoid arthritis patients [43].
  • Rheumatoid patients with diabetes had an increased risk of wound infection (33%) compared with patients without diabetes (3.3%) [33].
  • Among patients with rheumatoid arthritis undergoing elective hand surgery, perioperative biologic disease-modifying antirheumatic drug continuation was not associated with significant increases in risks of wound healing failures or surgical site infections [56].

Non-Operative Rehabilitation and Exercise

  • There is not strong research evidence for or against the value of hand exercise in the treatment of persons with rheumatoid arthritis, although results suggest that appropriate exercise might lead to long-term strength changes and very short-term changes in stiffness [19].
  • Supervised high-intensity interval training and strength exercise appear to be feasible and well tolerated by patients and could be recommended to improve cardiovascular and physical health in patients with well-controlled rheumatoid arthritis [51].
  • No outcome studies on the effectiveness of joint protection programs for unstable metacarpophalangeal joints in rheumatoid arthritis were found [58].

Outcomes and Prognosis

  • Patients with rheumatoid arthritis who underwent Swanson Metacarpophalangeal Joint Arthroplasty had significant improvements in patient-reported outcomes at the 1-year interval [21].
  • Following total shoulder arthroplasty, rheumatoid arthritis patients should be considered at higher risk of systemic and joint-related complications compared to patients with primary osteoarthritis [13].
  • Shoulder arthroplasty in patients with rheumatoid arthritis reduces pain and improves function [35].
  • Although patients with rheumatoid arthritis may be at an increased risk of complications and revision surgery, patients can expect reduced pain and improved functional outcomes similar to those with osteoarthritis following primary total hip arthroplasty [22].
  • Total knee arthroplasty in patients who have rheumatoid arthritis yields significant improvement in physician- and patient-reported outcomes [36].
  • In the largest single-institution study to date, patients with rheumatoid arthritis reported poorer patient-reported outcome scores compared with the osteoarthritis and posttraumatic arthritis groups but experienced functional outcome improvement from the preoperative baseline following total ankle arthroplasty [24].
  • Patient-reported functional outcomes at 6 months for total elbow arthroplasty were significantly lower in the fracture group compared to osteoarthritis and rheumatoid arthritis groups [25].
  • Despite comparable complication rates between rheumatoid arthritis and non-rheumatoid arthritis cohorts, further investigation into the underlying mechanisms of increased revision rates in rheumatoid arthritis patients undergoing total elbow arthroplasty is warranted [7].
  • Age, disease duration, disease activity score, and deformity were associated with the lowest brief Michigan Hand Outcomes Questionnaire scores in rheumatoid arthritis patients [34].
  • Patients with rheumatoid arthritis can differentiate between problems caused by their hands and other effects of their disease using a visual analogue scale [6].
  • In rheumatoid arthritis trials, grip strength should be assessed at the same time of the day [57].
  • A 48% decrease in the number of primary arthroplasties performed for rheumatoid arthritis was found in a review of the Finnish Arthroplasty Register covering 1995 to 2010, attributed to the effectiveness of improved medical management [43].

Key Considerations

General Management and Assessment

  • A system of radiographic grading for rheumatoid, psoriatic, and other similar arthritic conditions is useful in evaluating cases for medical and surgical treatment and epidemiologic studies [17].
  • Rheumatoid arthritis is not a modern disease and was not brought to the Old World from the New World after the discovery of America [11].

Non-Operative Considerations

  • There is not strong research evidence for or against the value of hand exercise in the treatment of persons with rheumatoid arthritis, although results suggest appropriate exercise might lead to long-term strength changes and very short-term changes in stiffness [19].

Operative Considerations

  • Although there is good reason to intervene early in the disease, there are no long-term studies with sufficient control to provide clear evidence of significant long-term benefits from synovectomy [37].
  • Long-term results of radiolunate arthrodesis are favorable as long as the rheumatoid process is under control [3].
  • Radiolunate arthrodesis in patients with rheumatoid arthritis maintained good clinical results and corrected alignment during long-term follow-up [79].
  • Silicone rubber implant arthroplasty of the metacarpophalangeal joint in rheumatoid arthritis is useful despite some deterioration of results during long-term follow-up [78].
  • In view of the paucity of long-term results for total elbow replacement, radial-head excision and synovectomy may retain a role in younger patients or in those whose symptoms are related mainly to the radiohumeral joint [39].
  • The long-term clinical results of elbow interposition arthroplasty in rheumatoid arthritis are good in terms of pain relief but only fair in terms of joint mobility and stability, and are probably inferior to those of total elbow replacement [81].
  • Total elbow replacement arthroplasty for rheumatoid arthritis appears durable at long-term follow-up [80].
  • The Kudo type-5 prosthesis demonstrated satisfactory results in patients with rheumatoid arthritis, although failures occurred to some extent over a long-term follow-up period [70].
  • Despite comparable complication rates between rheumatoid arthritis and non-RA cohorts, further investigation into the underlying mechanisms of increased revision rates in rheumatoid arthritis patients is warranted [7].
  • In the largest single-institution study to date, patients with rheumatoid arthritis reported poorer patient-reported outcome scores compared with osteoarthritis and posttraumatic arthritis groups but experienced functional outcome improvement from the preoperative baseline after total ankle arthroplasty [24].
  • Comparative outcomes of robot-assisted versus conventional total knee arthroplasty provide important evidence for selecting surgical methods in rheumatoid osteoarthritis [30].
  • Flexor pollicis longus rupture in patients with rheumatoid arthritis gives short-term dysfunction but, in most cases, not substantial medium-term dysfunction [27].
  • Clinical and radiological assessments at 22 months of follow-up for surgical reconstruction of an unstable rheumatoid thumb deformity revealed good outcomes [75].

Radiographic and Pathologic Findings

  • Bone destruction in both the humerus and the olecranon appears to be a late consequence of rheumatoid elbow involvement [82].
  • The distal radioulnar joint showed a rapid increase in Larsen score and was involved in 78% of patients on late x-rays in longitudinal radiographic analysis of rheumatoid arthritis in the hand and wrist [83].
  • Rheumatoid nodules are often associated with the poor prognosis for the severe form of rheumatoid disease [9].
  • A misdiagnosis of rheumatoid nodules can occur secondary to the patient’s history of rheumatoid arthritis, as seen in cases of multiple epidermal inclusion cysts [23].

Key Evidence

  • [L5] The success of treatment of patients with rheumatoid arthritis depends on a clear understanding of the drugs available and of what can be done at various stages of the disease. [1] (10.1016/s0363-5023(83)80240-8)
  • [Paper] The Arthritis Committee recognizes the profound importance of arthritic disorders to the general population, not only as a health problem, but for their social and economic impact. [2] (10.1016/s0363-5023(83)80245-7)
  • [L4] Long-term results are favorable, as long as the rheumatoid process is under control. [3] (10.1016/s0363-5023(86)80034-x)
  • [L4] These data establish a novel tool for pre-clinical research of early arthritis and have implications for early RA detection and monitoring of therapeutic efficacy in humans. [4] (10.1002/jor.24900)
  • [L5] The purpose of this study was to determine how economic, social, and cultural factors affect rheumatoid hand treatment in selected countries representing various regions of the world. [5] (10.1016/j.jhsa.2004.11.012)
  • [L4] Patients with rheumatoid arthritis can differentiate between problems caused by their hands and other effects of their disease. [6] (10.1016/s0894-1130(04)00197-8)
  • [L3] Despite comparable complication rates between RA and non-RA cohorts, further investigation into the underlying mechanisms of increased revision rates in RA patients is warranted. [7] (10.1016/j.jse.2024.12.032)
  • [Paper] Surgery for Rheumatoid Arthritis provides a comprehensive yet concise review of medical considerations, surgical principles, and regional surgical considerations as they apply to the patient with rheumatoid arthritis. [8] (10.1016/0363-5023(93)90415-y)
  • [L5] This is in contrast to the poor prognosis for the severe form of rheumatoid disease with which rheumatoid nodules are often associated. [9] (10.1016/s0363-5023(84)80232-4)
  • [L4] These data likely reflect skewed utilization of bDMARDs in rheumatoid arthritis patients with more severe disease and prolonged periods of joint degeneration because of prior treatment failure. [10] (10.5435/jaaosglobal-d-22-00209)
  • [L5] These retrospective case reports, in conjunction with other pictorial depictions of probable rheumatoid arthritis, question the belief of some clinicians that rheumatoid arthritis is a modern disease and that it was brought to the Old World from the New World after the discovery of America. [11] (10.1016/s0894-1130(96)80080-9)
  • [L4] Rheumatoid wrist involvement in black patients was more or less the same as reported in other series, but finger joint involvement was considerably less. [12] (10.1016/s0266-7681(03)00096-2)
  • [L3] Following TSA, RA patients should be considered at higher risk of systemic and joint-related complications compared to patients with primary OA. [13] (10.5397/cise.2024.00374)
  • [L4] Clinical symptoms and radiologic appearances are often poor indicators of the source of pain in the shoulder joint complex in patients with rheumatoid arthritis. [14] (10.1016/s1058-2746(09)80111-0)
  • [L4] Rheumatologists view rheumatoid hand surgery as significantly less effective than do hand surgeons, which highlights the disagreements between the 2 specialties about the management of this clinical problem. [15] (10.1053/jhsu.2003.50034)
  • [L1] Denosumab demonstrates promising efficacy in maintaining bone health and preventing joint damage in rheumatoid arthritis patients with coexisting osteoporosis. [16] (10.1186/s12891-025-08688-8)
  • [Paper] This system of radiographic grading for rheumatoid, psoriatic, and other similar arthritic conditions can be useful in evaluating cases for both medical and surgical treatment and epidemiologic studies. [17] (10.1016/s0363-5023(83)80241-x)
  • [L5] This review outlines the skin, vascular and musculoskeletal symptoms affecting the hand during systemic inflammatory diseases other than rheumatoid arthritis. [18] (10.1016/j.main.2014.01.008)
  • [L1] There is not strong research evidence for or against the value of hand exercise in the treatment of persons with rheumatoid arthritis, although results of this review suggest that appropriate exercise might lead to long-term strength changes and very short-term changes in stiffness. [19] (10.1197/j.jht.2004.02.006)
  • [L5] Surgery for RA and other inflammatory diseases is not disappearing. [20] (10.1016/j.main.2014.09.003)
  • [L2] Our data show that patients with RA who underwent SMPA had significant improvements in patient-reported outcomes at the 1-year interval. [21] (10.1016/j.jhsa.2004.03.004)
  • [L3] Although patients with rheumatoid arthritis may be at an increased risk of complications and revision surgery, patients can expect reduced pain and improved functional outcomes similar to those with osteoarthritis following primary THA. [22] (10.5435/jaaos-d-24-00656)
  • [L5] A misdiagnosis of rheumatoid nodules was made secondary to the patient’s history of rheumatoid arthritis. [23] (10.1053/jhsu.2000.8641)
  • [L3] In the largest single-institution study to date, patients with RA reported poorer PRO scores compared with the OA and posttraumatic arthritis groups but experienced functional outcome improvement from the preoperative baseline. [24] (10.2106/jbjs.24.00048)
  • [L3] Patient-reported functional outcomes at 6 months were significantly lower in the fracture group compared to osteoarthritis and rheumatoid arthritis groups. [25] (10.1016/j.jse.2026.01.019)
  • [Paper] The book 'Monoclonal antibodies, cytokines, and arthritis' presents the latest concepts regarding the molecular biology and immunology of arthritides, as well as a new rationale for treatment. [26] (10.1016/0363-5023(93)90283-9)
  • [L4] FPL rupture in patients with RA gives short term dysfunction but, in most cases, not substantial medium-term dysfunction. [27] (10.1016/j.hansur.2020.08.002)
  • [L4] In vivo, mechanically impaired tendons may play an important role in destabilization of the wrist in patients with rheumatoid arthritis. [28] (10.1002/jor.1100160412)
  • [L4] These findings contrast with rheumatoid arthritis, where mineralization is maintained and there is no predominant periarticular osteopenia. [29] (10.1016/j.hansur.2018.10.169)
  • [L3] This provides important evidence for selecting surgical methods in rheumatoid osteoarthritis. [30] (10.1186/s13018-026-06703-9)
  • [L4] The results of our survey suggest that there is limited knowledge of anti-TNFa and no consensus of opinion amongst hand surgeons performing rheumatoid surgery in the UK with regard to its perioperative use. [31] (10.1016/j.jhsb.2006.04.006)
  • [L4] Rheumatoid patients with diabetes had an increased risk of wound infection (33%) compared with patients without (3.3%). [33] (10.1053/jhsu.2002.32958)
  • [L4] Age, disease duration, disease activity score and deformity were associated with the lowest bMHQ scores in RA patients. [34] (10.1016/j.hansur.2016.09.003)
  • [L3] Shoulder arthroplasty in patients with rheumatoid arthritis reduces pain and improves function. [35] (10.1186/s13018-025-06109-z)
  • [L3] Total knee arthroplasty in patients who have RA yields significant improvement in physician- and patient-reported outcomes. [36] (10.1016/j.arth.2026.03.021)
  • [L5] Although there is good reason to intervene early in the disease there are no long-term studies with sufficient control to provide clear evidence of significant long-term benefits from synovectomy. [37] (10.1016/0266-7681(92)90125-l)
  • [L4] Hand involvement in psoriatic arthritis differs from rheumatoid arthritis, characterized by stiffness and spontaneous fusion rather than instability. [38] (10.1016/s0363-5023(82)80090-7)
  • [L3] In view of the paucity of long-term results for TER, RHES may retain a role in younger patients or in those whose symptoms are related mainly to the radiohumeral joint. [39] (10.1016/s1058-2746(99)90147-7)
  • [L3] Inflammatory arthritis represents a distinctly morbid risk profile compared to osteoarthritis patients with multiple increased surgical and postoperative medical complications in patients undergoing aTSA and rTSA. [40] (10.1016/j.jse.2023.09.014)
  • [L4] This supports the concept that the ongoing rheumatoid process is responsible for the translocation. [41] (10.1016/j.jhsb.2003.10.007)
  • [L4] When subjects with rheumatoid arthritis were analyzed, it was determined that early in the disease process bone erosions may occur in the sigmoid notch of the distal radius. [44] (10.1016/s0363-5023(05)80140-6)
  • [L5] The severe joint destruction that subsequently occurred may have been the result of prolonged sepsis, development of an autoimmune response to Candida breakdown products, or a combination of these factors. [45] (10.1016/s1058-2746(05)80041-2)
  • [L4] In parallel, the density of synovial cells increased after synovectomy in all control subjects and six of eight RA patients, which is indicative of a wound healing response. [46] (10.1002/jor.21233)
  • [Paper] Inflammatory arthritis has a substantial effect in producing intracortical defects in metaphyseal bone, but the bisphosphonate zoledronate was considerably effective in preventing these changes from occurring. [47] (10.1002/jor.1100150610)
  • [L4] Type II collagen was present in all attachment zones, although there was little in rheumatoid fingers. [48] (10.1016/0266-7681(93)90067-p)
  • [L4] Juvenile rheumatoid arthritis seldom involves the small joints of the hand, but proximal interphalangeal joint synovitis can be the initial manifestation. [49] (10.1016/s0363-5023(86)80148-4)
  • [L5] All care plans should be made with thoughtful consideration to the patient's other joint involvement, functional needs, and their lifestyle. [50] (10.1097/00130911-200003000-00010)
  • [L1] Supervised HIIT and strength exercise appear to be feasible and well tolerated by patients and could be recommended to improve cardiovascular and physical health in patients with well-controlled RA. [51] (10.1136/bjsports-2024-108369)
  • [L5] In all facets of treatment or evaluation, the rheumatoid patient must be handled gently with respect of tissue response and pain. [52] (10.1016/s0894-1130(96)80074-3)
  • [L5] Tectochrysin may be a novel RA therapeutic agent, likely acting via macrophage JAK/STAT pathway inhibition, with promising clinical potential. [53] (10.1186/s13018-025-06481-w)
  • [L3] Two-thirds of patients with rheumatic conditions visiting a multidisciplinary hand clinic reportedly followed the treatment advice (recommendations), with an overall trend toward a beneficial effect on hand function. [54] (10.1197/j.jht.2007.04.004)
  • [L2] Among patients with RA undergoing elective hand surgery, perioperative bDMARD continuation was not associated with significant increases in risks of wound healing failures or SSIs. [56] (10.1016/j.jhsa.2026.03.003)
  • [L4] In rheumatoid arthritis trials, grip strength should be assessed at the same time of the day. [57] (10.1016/s0363-5023(09)91074-7)
  • [Paper] No outcome studies on the effectiveness of joint protection programs for unstable MCP joints in RA were found. [58] (10.1197/j.jht.2006.04.009)
  • [L1] There is preclinical evidence for an antioxidant, anti-inflammatory, antinociceptive, cartilage- and bone-protective effect of CT in RA and OA. [59] (10.1530/eor-23-0133)
  • [L4] Single-digit swelling may be a presenting feature of JRA in 18% of cases. [60] (10.1016/s0363-5023(97)80124-4)
  • [L4] The severity of the patient's disease and the degree of articular involvement had a great effect on the outcome of surgery. [63] (10.1016/0363-5023(88)90260-2)
  • [L4] Radiologic examination showed that all patients exhibited resorption of the distal ulna (mean 4.4 mm) and that resorption was worst in the group with rheumatoid arthritis. [65] (10.1016/0363-5023(90)90099-d)
  • [L5] The use of contrast arthrography can provide evidence as to the presence and prominence of rheumatoid synovitis at the elbow. [67] (10.1016/0266-7681(86)90032-x)
  • [Paper] These results show that invasive tenosynovium is more destructive than encapsulating tenosynovium at a molecular level, providing an explanation for the increased tendon rupture associated with invasive tenosynovitis in RA. [68] (10.1053/jhsu.2002.36516)
  • [L4] Although the Kudo type-5 prosthesis demonstrated satisfactory results in patients with RA, failures occurred to some extent over a long-term follow-up period. [70] (10.1016/j.jse.2024.10.025)
  • [L4] Overall functional results often were affected by the status of disease in other joints, but in general were acceptable. [71] (10.1016/s0363-5023(78)80002-1)
  • [L5] Surgery of the rheumatoid hand must take account of the severity of the disease, with sero-positive patients with high sedimentation rates being informed about and trained in principles of joint protection before operation. [72] (10.1016/0266-7681(89)90078-8)
  • [L2] Understanding which factors are associated with choosing rheumatoid hand reconstruction is an essential component of patient preoperative counseling. [73] (10.1016/j.jhsa.2005.10.005)
  • [L4] It is shown that overall there is a significantly lower incidence of Dupuytren's features in patients with rheumatoid diseases, than there is in random control patients. [74] (10.1016/s0266-7681(84)80020-0)
  • [L5] Clinical and radiological assessments at 22 months of follow-up revealed good outcomes. [75] (10.1016/j.main.2015.02.004)
  • [L4] Despite some deterioration of the results during the long-term follow-up, we found that this method of prosthetic replacement of the MP joints in RA is useful. [78] (10.1016/s0363-5023(86)80138-1)
  • [L4] Radiolunate arthrodesis in patients with RA maintained good clinical results and corrected alignment, even during long-term follow-up. [79] (10.1016/j.jhsa.2022.11.014)
  • [L4] The results appear durable at long term followup. [80] (10.1016/s1058-2746(96)80507-6)
  • [L4] The long-term clinical results of elbow interposition arthroplasty in rheumatoid arthritis are good in terms of pain relief but only fair in terms of joint mobility and stability and as a whole are probably inferior to those of total elbow replacement. [81] (10.1016/s1058-2746(96)80001-2)
  • [L3] Bone destruction in both the humerus and the olecranon appears to be a late consequence of rheumatoid elbow involvement. [82] (10.1067/mse.2002.123903)
  • [L4] The distal radioulnar joint showed a rapid increase in Larsen score and was involved in 78% of patients on late x-rays. [83] (10.1053/jhsu.2003.50070)

References

[1] Medical considerations and management of rheumatoid arthritis. The Journal of Hand Surgery. 1983. DOI: 10.1016/s0363-5023(83)80240-8

[2] Report of the Arthritis Committee. The Journal of Hand Surgery. 1983. DOI: 10.1016/s0363-5023(83)80245-7

[3] Radiolunate arthrodesis in the rheumatoid wrist. The Journal of Hand Surgery. 1986. DOI: 10.1016/s0363-5023(86)80034-x

[4] Cy3‐tilmanocept labeling of macrophages in joints of mice with antibody‐induced arthritis and synovium of human patients with rheumatoid arthritis. Journal of Orthopaedic Research. 2020. DOI: 10.1002/jor.24900

[5] A Qualitative Assessment of Rheumatoid Hand Surgery in Various Regions of the World. The Journal of Hand Surgery. 2005. DOI: 10.1016/j.jhsa.2004.11.012

[6] Visual analogue scale for assessment of the impact of rheumatoid arthritis in the hand. Journal of Hand Therapy. 2004. DOI: 10.1016/s0894-1130(04)00197-8

[7] Rates of long-term risk of revision and complications in total elbow arthroplasty in patients with rheumatoid arthritis: a propensity score-matched analysis. Journal of Shoulder and Elbow Surgery. 2025. DOI: 10.1016/j.jse.2024.12.032

[8] Surgery for rheumatoid arthritis: a comprehensive team approach. The Journal of Hand Surgery. 1993. DOI: 10.1016/0363-5023(93)90415-y

[9] Rheumatoid nodulosis of the hand. The Journal of Hand Surgery. 1984. DOI: 10.1016/s0363-5023(84)80232-4

[10] Trends in Total Joint Arthroplasty Among Patients With Rheumatoid Arthritis: The Effect of Recent Disease Modifying Antirheumatic Drug Utilization Guidelines. JAAOS: Global Research and Reviews. 2022. DOI: 10.5435/jaaosglobal-d-22-00209

[11] Rheumatoid Deformities in Paintings. Journal of Hand Therapy. 1996. DOI: 10.1016/s0894-1130(96)80080-9

[12] The Rheumatoid Wrist in Black South African Patients. Journal of Hand Surgery. 2003. DOI: 10.1016/s0266-7681(03)00096-2

[13] Rheumatoid arthritis is associated with higher 90-day systemic complications compared to osteoarthritis after total shoulder arthroplasty: a cohort study. Clinics in Shoulder and Elbow. 2024. DOI: 10.5397/cise.2024.00374

[14] The source of shoulder pain in rheumatoid arthritis: Usefulness of local anesthetic injections. Journal of Shoulder and Elbow Surgery. 1994. DOI: 10.1016/s1058-2746(09)80111-0

[15] Effectiveness of rheumatoid hand surgery: Contrasting perceptions of hand surgeons and rheumatologists. The Journal of Hand Surgery. 2003. DOI: 10.1053/jhsu.2003.50034

[16] Efficacy of denosumab in treatment of osteoporosis in patients with rheumatoid arthritis: a meta-analysis of randomized controlled trial. BMC Musculoskeletal Disorders. 2025. DOI: 10.1186/s12891-025-08688-8

[17] Radiographic evaluation of rheumatoid arthritis by standard reference films. The Journal of Hand Surgery. 1983. DOI: 10.1016/s0363-5023(83)80241-x

[18] The hand in systemic diseases other than rheumatoid arthritis. Chirurgie de la Main. 2014. DOI: 10.1016/j.main.2014.01.008

[19] The effectiveness of hand exercises for persons with rheumatoid arthritis: a systematic review. Journal of Hand Therapy. 2004. DOI: 10.1197/j.jht.2004.02.006

[20] Rheumatoid arthritis surgery has not disappeared!. Chirurgie de la Main. 2014. DOI: 10.1016/j.main.2014.09.003

[21] A prospective outcomes study of Swanson Metacarpophalangeal Joint Arthroplasty for the rheumatoid hand. The Journal of Hand Surgery. 2004. DOI: 10.1016/j.jhsa.2004.03.004

[22] Patient-Reported Outcome Measures After Direct Anterior Total Hip Arthroplasty Are Comparable Between Patients With Rheumatoid Arthritis and Osteoarthritis: A Propensity-Matched Analysis. Journal of the American Academy of Orthopaedic Surgeons. 2024. DOI: 10.5435/jaaos-d-24-00656

[23] Multiple epidermal inclusion cysts in a patient with rheumatoid arthritis: A case report. The Journal of Hand Surgery. 2000. DOI: 10.1053/jhsu.2000.8641

[24] Complication Rates and Functional Outcomes After Total Ankle Arthroplasty in Patients with Rheumatoid Arthritis. Journal of Bone and Joint Surgery. 2025. DOI: 10.2106/jbjs.24.00048

[25] A comparison of survivorship and functional outcomes for total elbow arthroplasty performed for distal humerus fracture, rheumatoid arthritis, and osteoarthritis, a New Zealand Joint Registry study. Journal of Shoulder and Elbow Surgery. 2026. DOI: 10.1016/j.jse.2026.01.019

[26] Monoclonal antibodies, cytokines, and arthritis. The Journal of Hand Surgery. 1993. DOI: 10.1016/0363-5023(93)90283-9

[27] The outcome of untreated flexor pollicis longus rupture in patients with rheumatoid arthritis. Hand Surgery and Rehabilitation. 2020. DOI: 10.1016/j.hansur.2020.08.002

[28] Mechanical properties of wrist extensor tendons are altered by the presence of rheumatoid arthritis. Journal of Orthopaedic Research. 1998. DOI: 10.1002/jor.1100160412

[29] Gout — does it looks like Rheumatoid Arthritis?. Hand Surgery and Rehabilitation. 2018. DOI: 10.1016/j.hansur.2018.10.169

[30] Comparative outcomes of robot-assisted versus conventional TKA in rheumatoid arthritis patients. Journal of Orthopaedic Surgery and Research. 2026. DOI: 10.1186/s13018-026-06703-9

[31] Survey on the Perioperative Use of TNFα Inhibitors in Rheumatoid Hand Surgery. Journal of Hand Surgery. 2006. DOI: 10.1016/j.jhsb.2006.04.006

[33] Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. The Journal of Hand Surgery. 2002. DOI: 10.1053/jhsu.2002.32958

[34] Brief Michigan Hand Outcomes Questionnaire in rheumatoid arthritis: A cross-sectional study of 100 patients. Hand Surgery and Rehabilitation. 2017. DOI: 10.1016/j.hansur.2016.09.003

[35] The moderating role of negative affect on pain in patients with rheumatoid arthritis who have undergone shoulder arthroplasty. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-06109-z

[36] Patient-Reported Outcomes and Satisfaction Following Total Knee Arthroplasty in Rheumatoid Arthritis: An Observational Cohort Study. The Journal of Arthroplasty. 2026. DOI: 10.1016/j.arth.2026.03.021

[37] Conservative Surgery in the Management of Rheumatoid Disease of the Hand and Wrist. Journal of Hand Surgery. 1992. DOI: 10.1016/0266-7681(92)90125-l

[38] Hand involvement in psoriatic arthritis. The Journal of Hand Surgery. 1982. DOI: 10.1016/s0363-5023(82)80090-7

[39] Surgery for rheumatoid arthritis of the elbow: A comparison of radial-head excision and synovectomy with total elbow replacement. Journal of Shoulder and Elbow Surgery. 1999. DOI: 10.1016/s1058-2746(99)90147-7

[40] Shoulder arthroplasty for inflammatory arthritis is associated with higher rates of medical and surgical complications: a nationwide matched cohort analysis from 2016-2020. Journal of Shoulder and Elbow Surgery. 2024. DOI: 10.1016/j.jse.2023.09.014

[41] Radiographic Changes after Resection of the Distal Ulna in Rheumatoid Arthritis. Journal of Hand Surgery. 2004. DOI: 10.1016/j.jhsb.2003.10.007

[43] Campbell S Operative Orthopaedics 4 Volume Set. SOFT-TISSUE PROCEDURES AND OSTEOTOMIES ABOUT THE KNEE > RHEUMATOID ARTHRITIS OF THE KNEE > ADULT-ONSET RHEUMATOID ARTHRITIS.

[44] Kinematics of the distal radioulnar joint in rheumatoid arthritis: An In vivo study using centrode analysis. The Journal of Hand Surgery. 1995. DOI: 10.1016/s0363-5023(05)80140-6

[45] Autoimmune arthritis caused by Candida septic arthritis. Journal of Shoulder and Elbow Surgery. 1995. DOI: 10.1016/s1058-2746(05)80041-2

[46] Surgical synovectomy decreases density of sensory nerve fibers in synovial tissue of non‐inflamed controls and rheumatoid arthritis patients. Journal of Orthopaedic Research. 2010. DOI: 10.1002/jor.21233

[47] Zoledronate (CGP 42'446), a bisphosphonate, protects against metaphyseal intracortical defects in experimental inflammatory arthritis. Journal of Orthopaedic Research. 1997. DOI: 10.1002/jor.1100150610

[48] Capsular Tissues of the Proximal Interphalangeal Joint: Normal Composition and Effects of Dupuytren’s Disease and Rheumatoid Arthritis. Journal of Hand Surgery. 1993. DOI: 10.1016/0266-7681(93)90067-p

[49] A unique presentation of juvenile rheumatoid arthritis: Proximal interphalangeal joint synovitis. The Journal of Hand Surgery. 1986. DOI: 10.1016/s0363-5023(86)80148-4

[50] General Principles of Rehabilitation After Surgical Reconstruction of the Rheumatoid Hand. Techniques in Hand & Upper Extremity Surgery. 2000. DOI: 10.1097/00130911-200003000-00010

[51] High-intensity interval training improves cardiovascular and physical health in patients with rheumatoid arthritis: a multicentre randomised controlled trial. British Journal of Sports Medicine. 2024. DOI: 10.1136/bjsports-2024-108369

[52] Management of Rheumatoid Arthritis of the Wrist. Journal of Hand Therapy. 1996. DOI: 10.1016/s0894-1130(96)80074-3

[53] Targeting macrophage JAK3/STAT3 signaling with tectochrysin: a novel therapeutic strategy to ameliorate bone erosion and synovitis in rheumatoid arthritis. Journal of Orthopaedic Surgery and Research. 2025. DOI: 10.1186/s13018-025-06481-w

[54] A Multidisciplinary Hand Clinic for Patients with Rheumatic Diseases: a Pilot Study. Journal of Hand Therapy. 2007. DOI: 10.1197/j.jht.2007.04.004

[56] Perioperative Biologic Disease-Modifying Antirheumatic Drugs, Risks of Infections, and Wound Complications in Patients With Rheumatoid Arthritis Undergoing Elective Hand Surgery. The Journal of Hand Surgery. 2026. DOI: 10.1016/j.jhsa.2026.03.003

[57] The effect of elbow flexion and time of assessment on the measurement of grip strength in rheumatoid arthritis. The Journal of Hand Surgery. 1992. DOI: 10.1016/s0363-5023(09)91074-7

[58] The Unstable Metacarpophalangeal Joint in Rheumatoid Arthritis: Anatomy, Pathomechanics, and Physical Rehabilitation Considerations. Journal of Hand Therapy. 2006. DOI: 10.1197/j.jht.2006.04.009

[59] Calcitonin treatment for osteoarthritis and rheumatoid arthritis – a systematic review and meta-analysis of preclinical data. EFORT Open Reviews. 2024. DOI: 10.1530/eor-23-0133

[60] Isolated digital swelling as the initial presentation of juvenile rheumatoid arthritis. The Journal of Hand Surgery. 1997. DOI: 10.1016/s0363-5023(97)80124-4

[63] Flexor tendon ruptures in patients with rheumatoid arthritis. The Journal of Hand Surgery. 1988. DOI: 10.1016/0363-5023(88)90260-2

[65] A critical analysis of Swanson ulnar head replacement arthroplasty: Rheumatoid versus nonrhematoid. The Journal of Hand Surgery. 1990. DOI: 10.1016/0363-5023(90)90099-d

[67] Elbow arthrography in the evaluation of posterior interosseous nerve compression in rheumatoid arthritis. The Journal of Hand Surgery: Journal of the British Society for Surgery of the Hand. 1986. DOI: 10.1016/0266-7681(86)90032-x

[68] The role of matrix metalloproteinases in rheumatoid tendon disease. The Journal of Hand Surgery. 2002. DOI: 10.1053/jhsu.2002.36516

[70] Long-term follow-up study of Kudo type-5 elbow prosthesis in patients with rheumatoid arthritis: minimum 10-year clinical outcomes. Journal of Shoulder and Elbow Surgery. 2025. DOI: 10.1016/j.jse.2024.10.025

[71] Interpositional arthroplasty for rheumatoid carpometacarpal joint disease. The Journal of Hand Surgery. 1978. DOI: 10.1016/s0363-5023(78)80002-1

[72] On surgery of the rheumatoid hand: Consensus and controversy. The Journal of Hand Surgery: Journal of the British Society for Surgery of the Hand. 1989. DOI: 10.1016/0266-7681(89)90078-8

[73] Reasons Why Rheumatoid Arthritis Patients Seek Surgical Treatment for Hand Deformities. The Journal of Hand Surgery. 2006. DOI: 10.1016/j.jhsa.2005.10.005

[74] The Incidence of Dupuytren’s Disease in Patients with Rheumatoid Arthritis. Journal of Hand Surgery. 1984. DOI: 10.1016/s0266-7681(84)80020-0

[75] Surgical reconstruction of an unstable rheumatoid thumb deformity. A case report. Chirurgie de la Main. 2015. DOI: 10.1016/j.main.2015.02.004

[78] Silicone rubber implant arthroplasty of the metacarpophalangeal joint in rheumatoid arthritis: A follow-up study of 32 patients. The Journal of Hand Surgery. 1986. DOI: 10.1016/s0363-5023(86)80138-1

[79] Radiolunate Arthrodesis in the Rheumatoid Wrist: A Retrospective Clinical and Radiologic Long-Term Follow-Up. The Journal of Hand Surgery. 2024. DOI: 10.1016/j.jhsa.2022.11.014

[80] Total elbow replacement arthroplasty for rheumatoid arthritis of the Elbow, long-term 5–20 year followup. Journal of Shoulder and Elbow Surgery. 1996. DOI: 10.1016/s1058-2746(96)80507-6

[81] Interposition arthroplasty of the elbow with rheumatoid arthritis. Journal of Shoulder and Elbow Surgery. 1996. DOI: 10.1016/s1058-2746(96)80001-2

[82] Bone destruction patterns of the rheumatoid elbow: A radiographic assessment of 148 elbows at 15 years. Journal of Shoulder and Elbow Surgery. 2002. DOI: 10.1067/mse.2002.123903

[83] Longitudinal radiographic analysis of rheumatoid arthritis in the hand and wrist. The Journal of Hand Surgery. 2003. DOI: 10.1053/jhsu.2003.50070

Creative Commons BY-NC 4.0

CC Creative Commons licence
BY Attribution — you must credit the source
NC NonCommercial — not for commercial use

Attribution-NonCommercial 4.0 International


Creative Commons Corporation ("Creative Commons") is not a law firm and does not provide legal services or legal advice. Distribution of Creative Commons public licenses does not create a lawyer-client or other relationship. Creative Commons makes its licenses and related information available on an "as-is" basis. Creative Commons gives no warranties regarding its licenses, any material licensed under their terms and conditions, or any related information. Creative Commons disclaims all liability for damages resulting from their use to the fullest extent possible.

Using Creative Commons Public Licenses

Creative Commons public licenses provide a standard set of terms and conditions that creators and other rights holders may use to share original works of authorship and other material subject to copyright and certain other rights specified in the public license below. The following considerations are for informational purposes only, are not exhaustive, and do not form part of our licenses.

Considerations for licensors: Our public licenses are intended for use by those authorized to give the public permission to use material in ways otherwise restricted by copyright and certain other rights. Our licenses are irrevocable. Licensors should read and understand the terms and conditions of the license they choose before applying it. Licensors should also secure all rights necessary before applying our licenses so that the public can reuse the material as expected. Licensors should clearly mark any material not subject to the license. This includes other CC- licensed material, or material used under an exception or limitation to copyright. More considerations for licensors: wiki.creativecommons.org/Considerations_for_licensors

Considerations for the public: By using one of our public licenses, a licensor grants the public permission to use the licensed material under specified terms and conditions. If the licensor's permission is not necessary for any reason--for example, because of any applicable exception or limitation to copyright--then that use is not regulated by the license. Our licenses grant only permissions under copyright and certain other rights that a licensor has authority to grant. Use of the licensed material may still be restricted for other reasons, including because others have copyright or other rights in the material. A licensor may make special requests, such as asking that all changes be marked or described. Although not required by our licenses, you are encouraged to respect those requests where reasonable. More considerations for the public: wiki.creativecommons.org/Considerations_for_licensees


Creative Commons Attribution-NonCommercial 4.0 International Public License

By exercising the Licensed Rights (defined below), You accept and agree to be bound by the terms and conditions of this Creative Commons Attribution-NonCommercial 4.0 International Public License ("Public License"). To the extent this Public License may be interpreted as a contract, You are granted the Licensed Rights in consideration of Your acceptance of these terms and conditions, and the Licensor grants You such rights in consideration of benefits the Licensor receives from making the Licensed Material available under these terms and conditions.

Section 1 -- Definitions.

a. Adapted Material means material subject to Copyright and Similar Rights that is derived from or based upon the Licensed Material and in which the Licensed Material is translated, altered, arranged, transformed, or otherwise modified in a manner requiring permission under the Copyright and Similar Rights held by the Licensor. For purposes of this Public License, where the Licensed Material is a musical work, performance, or sound recording, Adapted Material is always produced where the Licensed Material is synched in timed relation with a moving image.

b. Adapter's License means the license You apply to Your Copyright and Similar Rights in Your contributions to Adapted Material in accordance with the terms and conditions of this Public License.

c. Copyright and Similar Rights means copyright and/or similar rights closely related to copyright including, without limitation, performance, broadcast, sound recording, and Sui Generis Database Rights, without regard to how the rights are labeled or categorized. For purposes of this Public License, the rights specified in Section 2(b)(1)-(2) are not Copyright and Similar Rights.

d. Effective Technological Measures means those measures that, in the absence of proper authority, may not be circumvented under laws fulfilling obligations under Article 11 of the WIPO Copyright Treaty adopted on December 20, 1996, and/or similar international agreements.

e. Exceptions and Limitations means fair use, fair dealing, and/or any other exception or limitation to Copyright and Similar Rights that applies to Your use of the Licensed Material.

f. Licensed Material means the artistic or literary work, database, or other material to which the Licensor applied this Public License.

g. Licensed Rights means the rights granted to You subject to the terms and conditions of this Public License, which are limited to all Copyright and Similar Rights that apply to Your use of the Licensed Material and that the Licensor has authority to license.

h. Licensor means the individual(s) or entity(ies) granting rights under this Public License.

i. NonCommercial means not primarily intended for or directed towards commercial advantage or monetary compensation. For purposes of this Public License, the exchange of the Licensed Material for other material subject to Copyright and Similar Rights by digital file-sharing or similar means is NonCommercial provided there is no payment of monetary compensation in connection with the exchange.

j. Share means to provide material to the public by any means or process that requires permission under the Licensed Rights, such as reproduction, public display, public performance, distribution, dissemination, communication, or importation, and to make material available to the public including in ways that members of the public may access the material from a place and at a time individually chosen by them.

k. Sui Generis Database Rights means rights other than copyright resulting from Directive 96/9/EC of the European Parliament and of the Council of 11 March 1996 on the legal protection of databases, as amended and/or succeeded, as well as other essentially equivalent rights anywhere in the world.

l. You means the individual or entity exercising the Licensed Rights under this Public License. Your has a corresponding meaning.

Section 2 -- Scope.

a. License grant.

1. Subject to the terms and conditions of this Public License, the Licensor hereby grants You a worldwide, royalty-free, non-sublicensable, non-exclusive, irrevocable license to exercise the Licensed Rights in the Licensed Material to:

a. reproduce and Share the Licensed Material, in whole or in part, for NonCommercial purposes only; and

b. produce, reproduce, and Share Adapted Material for NonCommercial purposes only.

2. Exceptions and Limitations. For the avoidance of doubt, where Exceptions and Limitations apply to Your use, this Public License does not apply, and You do not need to comply with its terms and conditions.

3. Term. The term of this Public License is specified in Section 6(a).

4. Media and formats; technical modifications allowed. The Licensor authorizes You to exercise the Licensed Rights in all media and formats whether now known or hereafter created, and to make technical modifications necessary to do so. The Licensor waives and/or agrees not to assert any right or authority to forbid You from making technical modifications necessary to exercise the Licensed Rights, including technical modifications necessary to circumvent Effective Technological Measures. For purposes of this Public License, simply making modifications authorized by this Section 2(a) (4) never produces Adapted Material.

5. Downstream recipients.

a. Offer from the Licensor -- Licensed Material. Every recipient of the Licensed Material automatically receives an offer from the Licensor to exercise the Licensed Rights under the terms and conditions of this Public License.

b. No downstream restrictions. You may not offer or impose any additional or different terms or conditions on, or apply any Effective Technological Measures to, the Licensed Material if doing so restricts exercise of the Licensed Rights by any recipient of the Licensed Material.

6. No endorsement. Nothing in this Public License constitutes or may be construed as permission to assert or imply that You are, or that Your use of the Licensed Material is, connected with, or sponsored, endorsed, or granted official status by, the Licensor or others designated to receive attribution as provided in Section 3(a)(1)(A)(i).

b. Other rights.

1. Moral rights, such as the right of integrity, are not licensed under this Public License, nor are publicity, privacy, and/or other similar personality rights; however, to the extent possible, the Licensor waives and/or agrees not to assert any such rights held by the Licensor to the limited extent necessary to allow You to exercise the Licensed Rights, but not otherwise.

2. Patent and trademark rights are not licensed under this Public License.

3. To the extent possible, the Licensor waives any right to collect royalties from You for the exercise of the Licensed Rights, whether directly or through a collecting society under any voluntary or waivable statutory or compulsory licensing scheme. In all other cases the Licensor expressly reserves any right to collect such royalties, including when the Licensed Material is used other than for NonCommercial purposes.

Section 3 -- License Conditions.

Your exercise of the Licensed Rights is expressly made subject to the following conditions.

a. Attribution.

1. If You Share the Licensed Material (including in modified form), You must:

a. retain the following if it is supplied by the Licensor with the Licensed Material:

i. identification of the creator(s) of the Licensed Material and any others designated to receive attribution, in any reasonable manner requested by the Licensor (including by pseudonym if designated);

ii. a copyright notice;

iii. a notice that refers to this Public License;

iv. a notice that refers to the disclaimer of warranties;

v. a URI or hyperlink to the Licensed Material to the extent reasonably practicable;

b. indicate if You modified the Licensed Material and retain an indication of any previous modifications; and

c. indicate the Licensed Material is licensed under this Public License, and include the text of, or the URI or hyperlink to, this Public License.

2. You may satisfy the conditions in Section 3(a)(1) in any reasonable manner based on the medium, means, and context in which You Share the Licensed Material. For example, it may be reasonable to satisfy the conditions by providing a URI or hyperlink to a resource that includes the required information.

3. If requested by the Licensor, You must remove any of the information required by Section 3(a)(1)(A) to the extent reasonably practicable.

4. If You Share Adapted Material You produce, the Adapter's License You apply must not prevent recipients of the Adapted Material from complying with this Public License.

Section 4 -- Sui Generis Database Rights.

Where the Licensed Rights include Sui Generis Database Rights that apply to Your use of the Licensed Material:

a. for the avoidance of doubt, Section 2(a)(1) grants You the right to extract, reuse, reproduce, and Share all or a substantial portion of the contents of the database for NonCommercial purposes only;

b. if You include all or a substantial portion of the database contents in a database in which You have Sui Generis Database Rights, then the database in which You have Sui Generis Database Rights (but not its individual contents) is Adapted Material; and

c. You must comply with the conditions in Section 3(a) if You Share all or a substantial portion of the contents of the database.

For the avoidance of doubt, this Section 4 supplements and does not replace Your obligations under this Public License where the Licensed Rights include other Copyright and Similar Rights.

Section 5 -- Disclaimer of Warranties and Limitation of Liability.

a. UNLESS OTHERWISE SEPARATELY UNDERTAKEN BY THE LICENSOR, TO THE EXTENT POSSIBLE, THE LICENSOR OFFERS THE LICENSED MATERIAL AS-IS AND AS-AVAILABLE, AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND CONCERNING THE LICENSED MATERIAL, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHER. THIS INCLUDES, WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, ABSENCE OF LATENT OR OTHER DEFECTS, ACCURACY, OR THE PRESENCE OR ABSENCE OF ERRORS, WHETHER OR NOT KNOWN OR DISCOVERABLE. WHERE DISCLAIMERS OF WARRANTIES ARE NOT ALLOWED IN FULL OR IN PART, THIS DISCLAIMER MAY NOT APPLY TO YOU.

b. TO THE EXTENT POSSIBLE, IN NO EVENT WILL THE LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY (INCLUDING, WITHOUT LIMITATION, NEGLIGENCE) OR OTHERWISE FOR ANY DIRECT, SPECIAL, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, EXEMPLARY, OR OTHER LOSSES, COSTS, EXPENSES, OR DAMAGES ARISING OUT OF THIS PUBLIC LICENSE OR USE OF THE LICENSED MATERIAL, EVEN IF THE LICENSOR HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSSES, COSTS, EXPENSES, OR DAMAGES. WHERE A LIMITATION OF LIABILITY IS NOT ALLOWED IN FULL OR IN PART, THIS LIMITATION MAY NOT APPLY TO YOU.

c. The disclaimer of warranties and limitation of liability provided above shall be interpreted in a manner that, to the extent possible, most closely approximates an absolute disclaimer and waiver of all liability.

Section 6 -- Term and Termination.

a. This Public License applies for the term of the Copyright and Similar Rights licensed here. However, if You fail to comply with this Public License, then Your rights under this Public License terminate automatically.

b. Where Your right to use the Licensed Material has terminated under Section 6(a), it reinstates:

1. automatically as of the date the violation is cured, provided it is cured within 30 days of Your discovery of the violation; or

2. upon express reinstatement by the Licensor.

For the avoidance of doubt, this Section 6(b) does not affect any right the Licensor may have to seek remedies for Your violations of this Public License.

c. For the avoidance of doubt, the Licensor may also offer the Licensed Material under separate terms or conditions or stop distributing the Licensed Material at any time; however, doing so will not terminate this Public License.

d. Sections 1, 5, 6, 7, and 8 survive termination of this Public License.

Section 7 -- Other Terms and Conditions.

a. The Licensor shall not be bound by any additional or different terms or conditions communicated by You unless expressly agreed.

b. Any arrangements, understandings, or agreements regarding the Licensed Material not stated herein are separate from and independent of the terms and conditions of this Public License.

Section 8 -- Interpretation.

a. For the avoidance of doubt, this Public License does not, and shall not be interpreted to, reduce, limit, restrict, or impose conditions on any use of the Licensed Material that could lawfully be made without permission under this Public License.

b. To the extent possible, if any provision of this Public License is deemed unenforceable, it shall be automatically reformed to the minimum extent necessary to make it enforceable. If the provision cannot be reformed, it shall be severed from this Public License without affecting the enforceability of the remaining terms and conditions.

c. No term or condition of this Public License will be waived and no failure to comply consented to unless expressly agreed to by the Licensor.

d. Nothing in this Public License constitutes or may be interpreted as a limitation upon, or waiver of, any privileges and immunities that apply to the Licensor or You, including from the legal processes of any jurisdiction or authority.


Creative Commons is not a party to its public licenses. Notwithstanding, Creative Commons may elect to apply one of its public licenses to material it publishes and in those instances will be considered the “Licensor.” The text of the Creative Commons public licenses is dedicated to the public domain under the CC0 Public Domain Dedication. Except for the limited purpose of indicating that material is shared under a Creative Commons public license or as otherwise permitted by the Creative Commons policies published at creativecommons.org/policies, Creative Commons does not authorize the use of the trademark "Creative Commons" or any other trademark or logo of Creative Commons without its prior written consent including, without limitation, in connection with any unauthorized modifications to any of its public licenses or any other arrangements, understandings, or agreements concerning use of licensed material. For the avoidance of doubt, this paragraph does not form part of the public licenses.

Creative Commons may be contacted at creativecommons.org.